Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-01-17
2006-01-17
Richter, Johann (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S256000, C514S307000, C544S333000, C544S335000, C544S405000, C546S167000, C546S176000, C546S256000
Reexamination Certificate
active
06987110
ABSTRACT:
The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 5624949 (1997-04-01), Heath, Jr. et al.
patent: 5721245 (1998-02-01), Davis et al.
patent: 6037475 (2000-03-01), Faul et al.
patent: 6153641 (2000-11-01), Bergstrand et al.
patent: 1057484 (2000-12-01), None
patent: 1120414 (2001-08-01), None
patent: WO 9517182 (1995-06-01), None
patent: WO 9811102 (1998-03-01), None
patent: WO 00/06564 (2000-02-01), None
patent: WO 00/21927 (2000-04-01), None
patent: WO 02/10158 (2002-02-01), None
patent: WO 02/38561 (2002-05-01), None
Davis, P.D. et al.: “Inhibitors of Protein Kinase C1 2,3-Bisarylmaleimides” Journal of Medicinal Chemistry, American Chemical Society. Washington, D.C., U.S. vol. 35, No. 1, 1992, pp. 177-184.
PCT Search Report dated Oct. 8, 2003 for PCT/US03/17569.
International J. Pharm, 1986, 33, 201-217.
J. Pharm. Sci., 1977, Jan 66(1), p1.
P. Xia, et al., J. Clin. Invest., 1996, 98, 2018.
H. Ishii, et al., J. Mol. Med., 1998, 76, 21.
Inoguchi, et al., Proc. Natl. Acad. Sci. USA, 1992, 89, 11059-11065.
Bastyr III, E.J. and Lu, J., Diabetes, 1993, 42, (Suppl. 1) 97A.
Hsieh, et al., Proc. Natl. Acad. Sci USA, 1991, 88, 9315-9319.
Hsieh, et al., J. Biol. Chem., 1993, 268, 15118-15126.
Murray, et al., J. Biol. Chem, 1993, 268, 15847-15853.
Bilder, G.E., et al., J. Pharmacol. Exp. Ther., 1990, 252, 526-530.
Matsumoto, H. and Sasaki, Y., Biochem. Biophys. Res. Commun., 1989, 158, 105-109.
Yan, S-F, et al., J. Biol. Chem., 2000, 275, 16, 11921-11928.
Ren, S., et al., Am. J. Physiol., 2000, 278, (4, Pt. 1), E656-E-662.
Muid, R.E., et al., FEBS Lett., 1990, 293, 169-172.
Sonoki, H. et al., Kokyu-To Junkan, 1989, 37, 669-674 (see English language Summary included therein).
Kobayashi, et al., Amer. Phys. Soc., 1994, H1214-H1220.
Toullec, D., et al., J. Biol. Chem., 1991, 266, 15771-15781.
Karasik, A., et al., J. Biol. Chem., 1990, 265, 10226-10231.
Chen, K.S., et al., Trans. Assoc. Am. Physicians, 1991, 104, 206-212.
Chin, J.E., et al, J. Biol. Chem., 1993, 268, 6338-6347.
Lee, T-S., et al., J. Clin. Invest., 1989, 83, 90-94.
Lee, T-S., et al., Proc. Natl. Acad. Sci. USA, 1989, 86, 5141-5145.
Craven, P.A. and Derubertis, F.R., J. Clin. Invest, 1989, 87, 1667-1675.
Wolf, B.A., et al., J. Clin. Invest., 1991, 87, 31-38.
Tesfamariam,B., et al., J. Clin. Invest., 1991, 87, 1643-1648.
Ishii, H., et al., Science, 1996, 272, 728-731.
X. Gu, et al., Circ. Res., 1994, 75, 926.
R. H. Strasser, et al., Circulation, 1996, 94, 1551.
H. Wakasaki, et al., Proc. Natl. Acad. Sci. USA, 1997, 94, 9320.
Twoemy, B., et al., Biochem. Biophys. Resl Commun., 1990, 171, 1087-1092.
Mulqueen, J.M., et al., Agents Actions, 1992, 37, 85-89.
Nechushtan, H., et al., Blood, 2000 (Mar.), 95, 5, 1752-1757.
Ren, S., et al., Am. J. Physiol., 2000, 278, (4, Pt. 1), E656-E-662.
Nagpala, P.G., et al., J. Cell Physiol., 1996, 2, 249-55.
Dekker, L.V., et al., Biochem. J., 2000, 347, 285-289.
Slater. M.J., et al., Biorg. & Med. Chem., 1999, 7, 1067-1074.
Rabbi, M.F., et al., Virology, 1998 (Jun. 5), 245, 2, 257-69.
Leitges, M., et al., Science (Wash., D.C.), 1996, 273, 5276, 788-789.
Horn, F., et al., J. Invest. Dermatol., 1987, 88, 220-222.
Raynaud, F. and Evain-Brion, D., Br. J. Dermatol., 1991, 124, 542-546.
Hegemann, L., et al., Arch. Dermatol. Res., 1991, 283, 456-460.
Bollag, W.B. et al., J. Invest. Dermatol., 1993, 100, 240-246.
Rotenberg, S.A. and Weinstein, I.B., Biochem. Mol. Aspects Sel. Cancer, 1991, 1, 25-73.
Ahmad, et al., Molecular Pharmacology, 1993, 43, 858-862.
Meyer, T., et al., Int. J. Cancer, 1989, 43, 851-856.
Akinagaka, S., et al., Cancer Res., 1991, 51, 4888-4892.
Sauma, S., et al., Cell Growth Differ., 1996, 7, 5, 587-94.
Konig, A., et al., Blood, 1997, 90, 10, Suppl. 1 Pt. 2.
Danso, D., et al., Proc. Am. Assoc. Cancer Res., 1997, 38, 88 Meet, 92.
Harrington, E.O., et al., J. Biol. Chem., 1997, 272, 11, 7390-7397.
Begemamm, M., et al., Anticancer Res. (Greece), 1998 (Jul.-Aug.), 18, 4A, 2275-82.
Teicher, B.A., et al., Proc. Am. Assoc. Cancer Res., 1998, 39, 89 Meet., 384.
Teicher, B.A. et al., Clinical Cancer Research, 2001 (Mar.), 7, 634-640.
Huang, K.P., Trends Neurosci., 1989, 12, 425-432.
Shimohama, S., et al., Neurology, 1993, 43, 1407-1413.
Hara, H., et al., J. Cereb. Blood Flow Metab., 1990, 10, 646-653.
Shibata, S., et al., Brain Res., 1992, 594, 290-294.
Beldhuis, H.J.A., et al., Neuroscience, 1993, 55, 4, 965-73.
Miletic, V., et al., Neurosci. Lett., 2000, 288, 3, 199-202.
Chen, C., et al., Science (Wash, D.C.), 1997, 278, 5336, 279-283.
Embi, et al., Eur. J. Biochem, 1980, 107, 519-527.
Cross, et al., Biochemical Journal, 1994, 303, 21-26.
Villar-Palasi C. and Larner J., Biochim. Biophys. Acta, 1960, 39, 171-173.
Parker, P.J., et al., Eur J. Biochem, 1983, 130, 227-234.
Cohen, P., Biochem. Soc. Trans., 1993, 21, 555-567.
Srivastava, A.K. and Pandey S.K., Mol. and Cellular Biochem., 1998, 182, 135-141.
Chen, et al., Diabetes, 1994, 43, 1234-1241.
Eldar-Finkelman, et al., PNAS, 1996, 93, 10228-10233.
Eldar-Finkelman and Krebs, PNAS, 1997, 94, 9660-9664.
Eldar-Finkelman, et al., Diabetes, 1999, 48, 1662-1666.
Gat, et al., Cell, 1998, 95, 605-614.
Hoeflich, K.P., et al., Nature, 2000, 406, 86-90.
Pap and Cooper, J. Biol. Chem., 1998, 273, 19929-19932.
D'Mello, et al., Exp. Cell Res., 1994, 211, 332-338.
Nonaka and Chuang, Neuroreport, 1998, 9(9), 2081-2084.
Hong, J. et al., J. Biol. Chem. 1997, 272(40), 25326-32.
Ikeda, et al., Embo J., 1998, 17, 1371-1384.
Eastman, Grosschedl, Curr. Opin. Cell Biol., 1999, 11, 233.
Cotter, D., et al., Neuroreport, 1998, 9, 1379-1383.
Lijam, N., et al., Cell, 1997, 90, 895-905.
Manji, et al., J. Clin. Psychiatry, 1990, 60, (Suppl 2) 27-39.
Conway Bruce R.
Demarest Keith
Maryanoff Bruce E.
Ye Hong
Zhang Han-Cheng
Janssen Pharmaceutica N.V.
Lopez Gabriel
Richter Johann
Sackey Ebenezer
Woodrow Hal B.
LandOfFree
Substituted pyrrolines as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolines as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolines as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3581298